1Oxman MN, Levin M J, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults [ J ]. N Engl J Med, 2005,352:2271 - 2284.
2US Food and Drug Administration. Product Approval Information-Licensing Action. Maryland, USA:US FDA. May 26,2006. http ://www. fda. gov/cber/products/zosmer052506qa, htm( accessed Oct 2,2006).
3Muir WB, Nichols R, Breuer J. Phylogenetic Analysis of Varicella - Zoster Virus:Evidence of Intercontinental Spread of Genotypes and Recombination [ J ]. Journal of Virology, 2002,76 : 1971 - 1979.
4Loparev VN, Gonzalez A, Deleon Carnes M, et al. Global identification of three major genotypes of varicella - zoster vires: longitudinal clustering and strategies for genotyping[ J]. J Viro1,2004 ,78 :8349 -8358.
6Plescia M, Leach L. Should the varicella vaccine to give all children to prevent chickenpox [ J ]. The Journal of Family Practice, 2004,53 ( 6 ) : 496 - 498.
8Thiry N, Beutels P, Shkedy Z, et al. The seroepidemiology of primary vailcelia zoster virus infection in Flanders ( Belgium ) [ J ]. Eur J Pediatr, 2002,161 ( 11 ) :588 -593.
9Wutzler P, Farber I, Wagenpfeil S, et al. Seroprevalence of varicella - zos- ter virus in the German population [ J ]. Vaccine,2001,20 ( 1 - 2 ) : 121 - 124.
10Babak Khoshnood, Monique Debruyne, Florian Lancon, et al. Seroprevalence of Varicella in the French Population[ J]. The Pediatric Infectious Disease Journal,2006,25 ( 1 ) :41 -44.
二级参考文献9
1Asano Y. Varicella vaccine:The Japanese experience [J] J Infect Dis, 1996,174(suppl 3):s310-313.
2Takahashi M . Prevention of virus-related neurological deseases by vaccines. Vaccine 1997,15(1):61-64.
3Beutels P. et al. Costs and benefits of routine varicella vaccination in German children. J Infect Dis 1996,174(supple 3):s335-s341.
